Partnering for Success: Accelerating Novel Molecular Diagnostics with Abingdon Health Abingdon Health partnered with the STRAND Project team SPARK at Stanford to develop a proof-of-concept for a novel molecular diagnostic platform. Abingdon Health’s technical expertise in lateral flow device design and component optimisation was crucial in proving the concept… Read More
How Adaptive Problem-Solving Transformed a Veterinary Diagnostic Breakthrough: Carus Animal Health aimed to develop a point-of-care lateral flow test to measure faecal calprotectin in dogs and cats. While measurement of faecal calprotectin is well established in human medicine, there was no equivalent test available for use in… Read More
Together with 9 other partner organisations, Abingdon Health plc is developing a rapid serological diagnostic test to detect Plasmodium vivax hypnozoites, which will be critical for malaria disease control, especially in remote areas. Coordinated by Michael White, Inès Vigan-Womas and… Read More
A leading global animal health organisation has contracted Abingdon Health since 2019 for end-to-end CDMO solutions. The project focused on optimising, transferring, and scaling up manufacturing processes, delivering a high-quality, market-ready lateral flow diagnostic device for animal care. Following successful delivery, Abingdon Health was retained for routine manufacturing spanning multi-deal… Read More